Our results showed that LCS-SeNPs reduced the pro-inflammatory cytokines TNF-α and IL-6 levels in serum and the colon of DSS-induced colitis mice, suggesting that LCS-SeNPs can achieve anti-inflammatory effects by reducing the serum levels of pro-inflammatory factors TNF-α and IL-6. Here, IL6 is linked to colitis.